Ph.D., CEO, L7 Informatics, Inc.
Biography
Dr. Vasu Rangadass, PhD is the CEO at L7 Informatics, Inc. Formerly Lab7 Systems, L7 (www.l7informatics.com) provides software and services that enable synchronized solutions for science + health. L7’s novel Enterprise Science Platform (ESP) is a scientific process and data management (SPDM) solution that enables life science and healthcare companies to connect people, processes, and systems to accelerate discoveries and drive precision healthcare. Prior to L7 Informatics, Dr. Rangadass was the Chief Strategy Officer at NantHealth following its acquisition of Net.Orange, the company he founded to provide an enterprise-wide platform – Clinical Operating System (cOS) to simplify and optimize care delivery processes in health systems. Holding several patents in “Master Data Management” (MDM), Enterprise “Operating Systems”, and Workflow Management (as well as extensive process experience in the Life Sciences & Healthcare Industries.
AI and Data Sciences Showcase:
L7 Informatics
L7 Informatics provides software and services that enable synchronized solutions for health systems and genomics research centers. L7’s Enterprise Science Platform (ESP) is a scientific information management (SIM) solution that allows these entities to manage and automate clinical research, molecular diagnostics, clinical trials, cell & gene therapies, and other complex treatment protocols by connecting people, electronic medical records systems, lab instrumentation, sequencing, and informatics software to optimize the diagnostic and treatment process while maintaining data integrity and regulatory compliance (Part 11, GLP, GCP & GMP). This system is a central resource that can orchestrate and synchronize patient diagnosis, treatment, and outcomes by combining phenotype and genotype data and enabling Informatics (AI/ML/Bio-Informatics) driven treatment decision support. Organizations including academic research centers, children’s hospitals, cancer centers are utilizing the platform for managing oncology, rare-disease, hereditary disease, and pharmaco-genomic pathways and have seen excellent results. For more information, please visit www.l7informatics.com.
Session Abstract – PMWC 2020 Silicon Valley
Track 7 - January 22 9.00 A.M.-3.45 P.M.,Track 6 - January 23 11.15 A.M.-11.30 A.M.,Track 2 - January 24 11.15 A.M.-4.00 P.M.
The PMWC 2020 AI Company Showcase will provide a 15-minute time slot for selected AI companies to present their latest technologies to an audience of leading investors, potential clients, and partners. We will hear from companies building technologies that expedite the pre-clinical and clinical drug discovery and development process, accelerate patient diagnosis and treatment, or develop scalable systems framework to make AI and deep/machine learning a reality.
